Visual outcomes, safety profile and morphometric response of optical coherence tomography biomarkers to ranibizumab biosimilar treatment in neovascular age-related macular degeneration: Real-world evidence
2021 ◽
2020 ◽
pp. bjophthalmol-2020-317434
2019 ◽
Vol 60
(15)
◽
pp. 4985
◽